288
Participants
Start Date
June 30, 2013
Primary Completion Date
January 31, 2018
Study Completion Date
July 31, 2019
Extended Release Naltrexone
naltrexone for extended release injectable suspension
Psychosocial Treatment
Psychosocial treatment will consist of group and individual drug abuse counseling at MMTC and in the community.
Buprenorphine
Participants assigned to TAU will receive buprenorphine for opioid withdrawal and will either be tapered off the medication or will remain on it for individualized lengths of time during the six month study.
Friends Research Institute, Baltimore
Mountain Manor Treatment Center, Baltimore
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NIH
Friends Research Institute, Inc.
OTHER